期刊文献+
共找到1,527篇文章
< 1 2 77 >
每页显示 20 50 100
Expression of heparanase gene,CD44v6,MMP-7 and nm23 protein and their relationship with the invasion and metastasis of gastric carcinomas 被引量:123
1
作者 Jun-QiangChen Wen-HuaZhan Yu-LongHe Jun-ShengPeng Jian-PingWang Shi-RongCai Jin-PingMa 《World Journal of Gastroenterology》 SCIE CAS CSCD 2004年第6期776-782,共7页
AIM:To explore the expression of heparanase gene, CD44v6,MMP-7 and nm23 proteins in human gastric carcinoma as well as their relationship with the dinicopathological factors.METHODS: Reverse transcription polymerase c... AIM:To explore the expression of heparanase gene, CD44v6,MMP-7 and nm23 proteins in human gastric carcinoma as well as their relationship with the dinicopathological factors.METHODS: Reverse transcription polymerase chain reaction (RT-PCR) was used to measure the expressions of heparanase mRNA in 43 human gastric carcinomas and 10 adjacent normal gastric tissues. Streptavidin-peroxidase (S-P) two step method was used to measure the immunohistochemical expression of CD44v6,MMP-7 and nm23protein in 43 human gastric carcinomas.RESULTS:The expression of heparanase gene was positivein 29 cases of gastric cancer with a positive rate of 67.4%,which was significantly higher than those in adjacent normal gastric tissues (P<0.05).The heparanase mRNA expression was significantly related to advanced stage of disease, serosal infitration,lymph node metastasis and size of tumors (P<0.05),but not related to tumor location, gross and histological types of the cancer, peritoneal dissemination and liver metastasis(P>0.05).The positive rate of CD44v6,nm23 and MMP-7 proteins was 76.7%,37.2% and 60.5%,respectively.The CD44v6 protein expression was significantly related to serosal infiltration,lymph node metastasis and TNM stage of disease(P<0.05).The nm23 protein expression was significantly related to the tumor gross appearance,lymph node and peritoneal metastasis (P<0.05).The MMP-7 protein expression was significantly related to serosal infiltration and TNM stage of disease (P<0.05).In an attempt to measure the association between these agents, we found that the expression of heparanase mRNA had significantly negative correlation with the expression of CD44v6 and MMP-7 protein (P<0.05), the expression of MMP-7 protein had significantly positive correlation with the expression of CD44v6 protein (r=0.568, P<0.05), the expression of MMP-7 protein had no correlation with the expression of nm23 protein (P>0.05),and the expression of nm23 protein had no correlation with the expression of CD44v6 protein (P>0.05).CONCLUSION: Despite their 展开更多
关键词 类肝素基因 cd44v6 基质金属蛋白-7 NM23蛋白 胃癌 肿瘤生物学 肿瘤侵袭
下载PDF
Expression and significance of CD44s, CD44v6, and nm23 mRNA in human cancer 被引量:63
2
作者 Yong-Jun Liu Pei-Song Yan +1 位作者 Jun Li Jing-Fen Jia 《World Journal of Gastroenterology》 SCIE CAS CSCD 2005年第42期6601-6606,共6页
AIM: To investigate the relationship between the expression levels of nm23 mRNA, CD44s, and CD44v6,and oncogenesis, development and metastasis of human gastric adenocarcinoma, colorectal adenocarcinoma,intraductal car... AIM: To investigate the relationship between the expression levels of nm23 mRNA, CD44s, and CD44v6,and oncogenesis, development and metastasis of human gastric adenocarcinoma, colorectal adenocarcinoma,intraductal carcinoma of breast, and lung cancer.METHODS: Using tissue microarray by immuhistochemical (IHC) staining and in situ hybri-dization (ISH), we examined the expression levels of nm23mRNA, CD44s, and CD44v6 in 62 specimens of human gastric adenocarcinoma and 62 specimens of colorectal adenocarcinoma; the expression of CD44s and CD44v6in 120 specimens of intraductal carcinoma of breast and 20 specimens of normal breast tissue; the expression of nm23 mRNA in 72 specimens of human lung cancer and 23 specimens of normal tissue adjacent to cancer.RESULTS: The expression of nm23 mRNA in the tissues of gastric and colorectal adenocarcinoma was not significantly different from that in the normal tissues adjacent to cancer (P>0.05), and was not associated with the invasion of tumor and the pathology grade of adenocarcinoma (P>0.05). However, the expression of nm23 mRNA was correlated negatively to the lymph node metastasis of gastric and colorectal adenocarcinoma (r = -0.49, P<0.01; r = -4.93, P<0.01). The expression of CD44s in the tissues of gastric and colorectal adenocarcinoma was significantly different from that in the normal tissues adjacent to cancer (P<0.05;P<0.01). CD44v6 was expressed in the tissues of gastric and colorectal adenocarcinoma only, the expression of CD44v6 was significantly associated with the lymph node metastasis, invasion and pathological grade of the tumor (r = 0.47, P<0.01; r = 5.04, P<0.01). CD44sand CD44v6 were expressed in intraductal carcinoma of breast, the expression of CD44s and CD44v6 was significantly associated with lymph node metastases and invasion (P<0.01). However, neither of them was expressed in the normal breast tissue. In addition, the expression of CD44v6 was closely related to the degree of cell differentiation of intraductal carcinoma of breast ( 展开更多
关键词 Tissue microarray Nm23 mRNA cd44S cd44v6 Gastric adenocarcinoma Colorectal adeno-carcinoma Intraductal carcinoma of breast Lung cancer
下载PDF
CD44 v6基因编码蛋白表达与胃癌转移和预后的关系 被引量:59
3
作者 辛彦 赵风凯 +3 位作者 张素敏 吴东瑛 王艳萍 徐蕾 《世界华人消化杂志》 CAS 1999年第3期210-214,共5页
目的观察转移相关粘附分子拼接变异体CD44v6在人胃癌组织中的不同表达,探讨CD44v6与胃癌病理生物学行为之间的关系,评价CD44v6可否作为一个新的客观预测胃癌细胞转移潜能和胃癌患者预后的可靠生物学指标.方法采用... 目的观察转移相关粘附分子拼接变异体CD44v6在人胃癌组织中的不同表达,探讨CD44v6与胃癌病理生物学行为之间的关系,评价CD44v6可否作为一个新的客观预测胃癌细胞转移潜能和胃癌患者预后的可靠生物学指标.方法采用鼠抗人CD44v6特异性mAb,对45例早期胃癌,22例中期胃癌和103例晚期胃癌手术切除标本之胃原发灶与转移灶进行了ABC免疫组化检测.应用χ2检验和Logrank检验方法对结果做统计学分析.结果CD44v6在晚期胃癌中的检出率为466%(48/103),明显高于早期胃癌(267%,12/45)和中期胃癌(273%,6/22,P<001).伴淋巴结转移和伴肝脏转移之胃癌CD44v6检出率分别为49%(50/102)和714%(5/7),明显高于不伴转移的胃癌(186%,11/59,P<001).肠型胃癌中CD44v6检出率为449%(48/107),明显高于弥漫型胃癌(274%,17/62,P<005).但是,CD44v6的表达与胃癌原发灶大小和组织学类型及分化程度未见明显相关.CD44v6阳性胃癌患者的术后生存期显著短于CD44v6阴性胃癌的患者(P=00002).结论? 展开更多
关键词 胃肿瘤 肿瘤转移 腺癌 cd44v6 基因表达 预后
下载PDF
胃癌淋巴结转移相关因素的多元分析 被引量:45
4
作者 张声 李莉 +1 位作者 林华 林建银 《中华肿瘤杂志》 CAS CSCD 北大核心 2001年第5期399-402,共4页
目的 探讨胃癌组织中CD44v6、基质金属蛋白酶 9(MMP 9)、金属蛋白酶抑制剂 1(TIMP 1)和结构型一氧化氮合酶 (cNOS)mRNA的表达等因素与胃癌侵袭转移的关系以及在预测胃癌淋巴结转移中的价值。方法 采用Logistic逐步回归的方法 ,对 11... 目的 探讨胃癌组织中CD44v6、基质金属蛋白酶 9(MMP 9)、金属蛋白酶抑制剂 1(TIMP 1)和结构型一氧化氮合酶 (cNOS)mRNA的表达等因素与胃癌侵袭转移的关系以及在预测胃癌淋巴结转移中的价值。方法 采用Logistic逐步回归的方法 ,对 119例原发性胃癌 10项与胃癌淋巴结转移有关的指标进行筛选。结果 胃癌组织中CD44v6表达越强 ,发生淋巴结转移的机率越高 ;MMP 9阳性表达而TIMP 1阴性表达者 ,发生淋巴结转移的机率最高 ;MMP 9阴性表达而TIMP 1阳性表达者 ,发生淋巴结转移的机率最低 ;胃癌血管或淋巴管内皮细胞cNOSmRNA阳性表达者 ,发生淋巴结转移的机率较高。结论 胃癌组织中CD44v6表达强度、MMP 9和TIMP 1表达失衡情况及胃癌血管或淋巴管内皮细胞cNOSmRNA的表达情况 ,可作为术前预测患者淋巴结转移的有效指标。 展开更多
关键词 胃肿瘤 淋巴结转移 Logistic逐渐回归 cd44v6 MMP-9 TIMP-1
原文传递
Expression of proliferating cell nuclear antigen and CD44 variant exon 6 in primary tumors and corresponding lymph node metastases of colorectal carcinoma with Dukes'stage C or D 被引量:37
5
作者 Ji-ChenqZhang Zuo-RenWang +5 位作者 Yan-JuanCheng Ding-ZhongYang Jing-SenShi Ai-LinLiang Ning-NaLiu Xiao-MinWang 《World Journal of Gastroenterology》 SCIE CAS CSCD 2003年第7期1482-1486,共5页
AIM: To study changes in characteristics of colorectal carcinoma during the metastatic process and to investigate the correlation between cell proliferation activity and metastatic ability of patients with Dukes′ sta... AIM: To study changes in characteristics of colorectal carcinoma during the metastatic process and to investigate the correlation between cell proliferation activity and metastatic ability of patients with Dukes′ stage C or D.METHODS: Formalin fixed and paraffin embedded materials of primary tumors and corresponding lymph node metastases resected from 56 patients with Dukes′ stage C or D of colorectal carcinoma were stained immunohistochemically with proliferating cell nuclear antigen (PCNA) and CD44variant exon 6 (CD44v6).RESULTS: Thirty-one of 56 patients (55.4 %) expressed PCNA in the primary sites and 36 of 56 patients (64.3 %)expressed PCNA in the metastatic lymph nodes. A significant relation in PCNA expression was observed between the primary site and the metastatic lymph node (0.010<P<0.025).Forty-one of 56 patients (73.2 %) expressed CD44v6 in the primary site and 39 of 56 patients (69.6 %) expressed CD44v6 in the metastatic lymph node. There was also an significant relationship of CD44v6 between the primary site and the metastatic lymph node (0.005<P<0.010). No difference was observed between expression of CD44v6 and PCNA in the primary site (0.250<P<0.500).CONCLUSION: This study partially demonstrates that tumor cells in metastatic lymph node of colorectal carcinoma still possess cell proliferation activity and metastatic ability of tumor cells in primary site. There may be no association between cell proliferation activity and metastatic ability in colorectal carcinoma. 展开更多
关键词 结肠直肠癌 淋巴结转移癌 细胞增殖 cd44v6 增殖细胞核抗原
下载PDF
小檗碱对人胃癌细胞增殖、细胞周期及CD44V6表达的影响 被引量:32
6
作者 娄金丽 邱全瑛 +3 位作者 林洪生 祁鑫 裴迎霞 何秀娟 《中国免疫学杂志》 CAS CSCD 北大核心 2004年第5期315-317,共3页
目的 :研究小檗碱对人胃癌MGC 80 3细胞增殖、细胞周期及CD4 4V6分子表达的影响 ,探讨其抗肿瘤及抗肿瘤转移作用机制。方法 :MTT法检测小檗碱对人胃癌MGC 80 3细胞体外增殖作用。激光共聚焦显微镜观察用药后细胞形态的改变并用流式细胞... 目的 :研究小檗碱对人胃癌MGC 80 3细胞增殖、细胞周期及CD4 4V6分子表达的影响 ,探讨其抗肿瘤及抗肿瘤转移作用机制。方法 :MTT法检测小檗碱对人胃癌MGC 80 3细胞体外增殖作用。激光共聚焦显微镜观察用药后细胞形态的改变并用流式细胞仪检测细胞周期的变化。应用免疫组化和流式细胞术技术检测药物对细胞表面CD4 4V6表达的影响。结果 :小檗碱对MGC 80 3细胞有显著抑制作用 ,在 10、2 0、4 0 μg ml浓度下 ,其抑制率分别为 36 2 %、4 9 7%和 5 9 3% ,有明显剂量依赖关系。激光共聚焦显微镜下细胞核固缩 ,并可见凋亡小体。药物可将细胞阻滞在G0 G1期 ,并使细胞表面的CD4 4V6表达降低。结论 :小檗碱可通过诱导MGC 80 3细胞凋亡并将细胞阻滞在G0 G1期 ,发挥抑制瘤细胞的体外增殖作用 ;小檗碱可降低MGC 80 3细胞株CD4 4V6的表达 。 展开更多
关键词 小檗碱 胃癌MGC-803 细胞周期 cd44v6
下载PDF
鳖甲煎丸对肝癌细胞中Wnt信号分子β-catenin、GSK-3β及靶基因CD44v6、VEGF的影响 被引量:36
7
作者 孙海涛 贺松其 +3 位作者 文彬 贾文燕 樊尔艳 郑艳 《南方医科大学学报》 CAS CSCD 北大核心 2014年第10期1454-1458,共5页
目的通过研究鳖甲煎丸对肝癌细胞HepG2中Wnt信号通路的信号分子及靶基因的影响,探讨鳖甲煎丸抗肝细胞癌转移侵袭的分子机制。方法使用含鳖甲煎丸药物血清培养肝癌细胞HepG2,48 h后采用Western blotting技术检测Wnt/β-catenin通路信号... 目的通过研究鳖甲煎丸对肝癌细胞HepG2中Wnt信号通路的信号分子及靶基因的影响,探讨鳖甲煎丸抗肝细胞癌转移侵袭的分子机制。方法使用含鳖甲煎丸药物血清培养肝癌细胞HepG2,48 h后采用Western blotting技术检测Wnt/β-catenin通路信号分子β-catenin、GSK-3β和磷酸化GSK-3β表达水平,免疫组化技术检测靶基因CD44v6、VEGF的表达情况。结果含鳖甲煎丸药物血清可以降低肝癌细胞HepG2中β-catenin表达水平,下调磷酸化GSK-3β表达水平,明显抑制CD44v6、VEGF的表达。结论鳖甲煎丸抗肝细胞癌转移侵袭的药理作用可能与其下调肝癌细胞HepG2中Wnt/β-catenin信号通路的信号分子β-catenin及磷酸化GSK-3β的表达水平并有效降低靶基因CD44v6、VEGF的表达水平具有相关性,这可能是鳖甲煎丸抑制肝癌细胞HepG2的生长、黏附及转移的重要分子机制之一。 展开更多
关键词 肝细胞癌 鳖甲煎丸 Β-连环蛋白 糖原合成酶激酶3Β cd44v6 血管内皮生长因子
下载PDF
复方苦参注射液对胃癌SGC-7901细胞侵袭转移能力的影响 被引量:28
8
作者 代志军 高洁 +5 位作者 仵文英 王西京 李宗芳 康华峰 刘小旭 马小斌 《中药材》 CAS CSCD 北大核心 2007年第7期815-819,共5页
目的:研究复方苦参注射液对胃癌SGC-7901细胞侵袭转移能力的影响。方法:体外培养胃癌细胞系SGC-7901,MTT法测定药物对细胞增殖的抑制作用,应用粘附试验、Transwell趋化运动和Matrigel侵袭实验,研究复方苦参注射液及其不同浓度下对SGC-7... 目的:研究复方苦参注射液对胃癌SGC-7901细胞侵袭转移能力的影响。方法:体外培养胃癌细胞系SGC-7901,MTT法测定药物对细胞增殖的抑制作用,应用粘附试验、Transwell趋化运动和Matrigel侵袭实验,研究复方苦参注射液及其不同浓度下对SGC-7901细胞的粘附、运动以及侵袭能力的影响。结果:复方苦参注射液浓度在0.25、0.5、1.0、1.5 mg/ml时均有一定的抑制胃癌SGC-7901细胞增殖的作用,且呈明显的量效和时效关系。复方苦参注射液不同浓度处理SGC-7901细胞后,体外粘附、侵袭和运动能力呈剂量依赖性下降。经复方苦参注射液(1.5 mg/ml)作用后SGC-7901细胞CD44V6蛋白表达减弱,胞浆棕黄色颗粒减少。结论:复方苦参注射液可以抑制胃癌细胞生长,降低细胞粘附、侵袭和运动能力,其机制可能与抑制CD44V6蛋白表达有关。 展开更多
关键词 胃癌 侵袭 粘附 转移 苦参注射液 cd44v6
下载PDF
CD44v6、bcl-2和VEGF在子宫内膜腺癌中的表达及其意义 被引量:28
9
作者 项达军 薛文群 +3 位作者 冯一中 陆以农 陈萍倩 王嘉园 《癌症》 SCIE CAS CSCD 北大核心 2003年第6期592-596,共5页
背景与目的:子宫内膜癌的发病机理至今尚未完全阐明,本研究拟探讨CD44v6、bcl-2、血管内皮生长因子(vascularendothelialgrowthfactor,VEGF)在子宫内膜腺癌发生、发展中的作用。方法:运用免疫组化技术SP法检测CD44v6、bcl-2、VEGF在55... 背景与目的:子宫内膜癌的发病机理至今尚未完全阐明,本研究拟探讨CD44v6、bcl-2、血管内皮生长因子(vascularendothelialgrowthfactor,VEGF)在子宫内膜腺癌发生、发展中的作用。方法:运用免疫组化技术SP法检测CD44v6、bcl-2、VEGF在55例子宫内膜腺癌及10例正常增生期子宫内膜、10例子宫内膜单纯性增生和10例不典型增生组织中的表达情况。结果:(1)在正常增生期子宫内膜、单纯性增生、不典型增生、子宫内膜腺癌中CD44v6及VEGF的阳性表达率分别为10.00%、40.00%、60.00%、78.18%和0%、0%、10.00%、83.84%,均有显著性差异(P<0.001,P<0.001),而bcl-2表达无显著差异;(2)55例子宫内膜腺癌组织中,CD44v6表达强度与手术分期及淋巴结有无转移呈负相关(P<0.05,P<0.01)bcl-2的表达强度在子宫内膜腺癌中与分化程度显著相关VEGF的表达强度与手术分期、肌层浸润、淋巴结有无转移显著相关;(3)bcl-2与VEGF、CD44v6在子宫内膜腺癌中有协同表达(P<0.05,P<0.05);(4)单因素生存分析CD44v及bcl-2与子宫内膜腺癌患者预后有关(P<0.01,P<0.05)多因素Cox模型分析筛选出患者的年龄、手术分期和CD44v是独立的预后影响因素,CD44v6阴性表达者的生存时间较阳性表达者短。结论:CD44v6、VEGF及bcl-2在子宫内膜腺癌的发生、发展过程中起不? 展开更多
关键词 cd44v6 BCL-2 vEGF 子宫内膜腺癌 临床意义 早期诊断 预后 免疫组织化学
下载PDF
Relationship between expression of CD44v6 and nm23-H1 and tumor invasion and metastasis in hepatocellular carcinoma 被引量:23
10
作者 XIAO Cheng Zhi, DAI Yi Min, YU Hong Yu, WANG Jian Jun and NI Can Rong 《World Journal of Gastroenterology》 SCIE CAS CSCD 1998年第5期49-51,共3页
AIM To detect the expression of CD44v6 mRNA and nm23-H1 mRNA in hepatocellular carcinoma (HCC) by in situ hybridization, and to evaluate the relationship between their expression and also relationship between their ex... AIM To detect the expression of CD44v6 mRNA and nm23-H1 mRNA in hepatocellular carcinoma (HCC) by in situ hybridization, and to evaluate the relationship between their expression and also relationship between their expressions and tumor invasion and metastasis.METHODS CD44v6 cDNA probe was synthesized with PCR technique and the nm23-H1 cRNA probe by in vitro transcription. The expression of CD44v6 mRNA and nm23-H1 mRNA was detected by in situ hybridization.RESULTS In group with high invasion and metastasis potential, the positive rates of CD44v6 mRNA and nm23-H1 mRNA were 80% (8/10) and 40% (4/10), in group with poor invasion and metastasis potential, they were 21.7% (5/23) and 91.3% (21/23). There was a positive correlation between the expression of CD44v6 mRNA and tumor invasion and metastasis potential in HCC (P<0.01), and a reverse correlation between the expression of nm23-H1 mRNA and tumor invasion and metastasis potential (P<0.01) and a reverse correlation in the expression between CD44v6 mRNA and nm23-H1 mRNA in HCC (P<0.01).CONCLUSION Detection of CD44v6 mRNA and nm23-H1 mRNA may be useful for tumor invasion and metastasis in HCC.INTRODUCTIONCD44 is a cell surface transmembrane glycoprotein. As a kind of adhesive molecule, it participates in cell-cell and cell-matrix adhesion and interactions. Many studies revealed a correlation between high-level expression of CD44, especially CD44v and tumor invasion, metastasis and prognosis. The exon 6v containing isoforms may be an independent diagnostic parameter[1,2]. Some other studies, however, had different results[3,4]. Some researches showed a reverse correlation between the expression of nm23-H1 mRNA and tumor metastasis[5,6]. In order to evaluate the relationship between the expression of CD44v6 mRNA and nm23-H1 mRNA and tumor invasive and metastatic potential in HCC and to evaluate the relationship in the expression between CD44v6 mRNA and nm23-H1 mRNA, we detected their expression in HCC by in situ hybridization. 展开更多
关键词 liver NEOPLASMS carcinoma hepatocellular NEOPLASM invasion NEOPLASM metastasis cd44v6 NM23 H1 RNA MESSENGER
下载PDF
消痰散结方对裸鼠MKN-45人胃腺癌组织中CD_(44)V_6表达的影响 被引量:22
11
作者 王建平 魏品康 +1 位作者 李毅华 许玲 《成都中医药大学学报》 2001年第3期20-21,共2页
目的 观察消痰散结方对裸鼠胃癌组织中胃癌细胞粘附分子CD4 4 V6 表达的影响 ,初步探讨消痰散结方抑制胃癌细胞转移的作用机理。方法 建立裸鼠MKN - 4 5人胃癌模型 ,采用免疫组化S -P法检测胃癌组织中CD4 4 V6 的表达。结果 中药组... 目的 观察消痰散结方对裸鼠胃癌组织中胃癌细胞粘附分子CD4 4 V6 表达的影响 ,初步探讨消痰散结方抑制胃癌细胞转移的作用机理。方法 建立裸鼠MKN - 4 5人胃癌模型 ,采用免疫组化S -P法检测胃癌组织中CD4 4 V6 的表达。结果 中药组胃癌组织中CD4 4 V6 表达水平明显低于空白对照组。结论 消痰散结方抑制胃癌细胞转移的作用机理可能与其能影响粘附分子的表达 。 展开更多
关键词 消痰散结方 中药药理学 胃腺癌 中医药治疗 cd44v6 燥湿化痰
下载PDF
结直肠癌组织中CD44v3,v6蛋白的表达意义 被引量:24
12
作者 蔡崎 陆洪芬 +3 位作者 孙孟红 杜祥 范月珍 施达仁 《世界华人消化杂志》 CAS 2000年第11期1255-1258,共4页
目的研究 CD44v3,v6蛋白在结直肠癌组织中的表达及其预后意义.方法应用 Envision^(TM)免疫组化法,回顾性分析121例结直肠癌石蜡组织 CD44v3,v6的表达.患者中位随访时间为67.77mo.结果 CD44v3,v6在结直肠癌中的阳性率分别为60.3%和57.9%.... 目的研究 CD44v3,v6蛋白在结直肠癌组织中的表达及其预后意义.方法应用 Envision^(TM)免疫组化法,回顾性分析121例结直肠癌石蜡组织 CD44v3,v6的表达.患者中位随访时间为67.77mo.结果 CD44v3,v6在结直肠癌中的阳性率分别为60.3%和57.9%.CD44v3的阳性表达与患者肿瘤部位,淋巴结转移状况、远处转移与否、临床分期密切相关(P<0.05,Spearman 等级相关检验).CD44v6的阳性表达与患者性别、淋巴结转移状况、远处转移与否、临床分期密切相关(P<0.05,Spearman 等级相关检验).Kaplan-Meier 生存曲线,Log-rank 检验单因素生存分析结果显示,CD44v3阴性、阳性患者的五年生存率分别为81.25%,60.27%,两者之间存在显著性差异(P=0.035);CD44v6阴性、阳性患者的5a 生存率分别为80.39%,60.00%,两者之间亦存在显著性差异(P=0.0299).Cox 模型多因素生存分析结果显示,CD44v3表达是影响结直肠癌预后的独立因素.结论 CD44v3,v6蛋白与结直肠癌转移、预后相关,CD44v3是影响结直肠癌预后的独立因素. 展开更多
关键词 结肠直肠肿瘤 cd44v3 cd44v6 EK
下载PDF
PI3K/AKT信号转导通路在肝癌细胞生长和黏附中的作用 被引量:21
13
作者 富翠芹 王沁 +1 位作者 尹蓉 武令启 《世界华人消化杂志》 CAS 北大核心 2008年第14期1493-1498,共6页
目的:探讨PI3K/AKT(磷脂酰肌醇-3-激酶/蛋白激酶B)信号转导通路在人肝癌细胞株SMMC-7221生长和黏附中的作用机制.方法:应用LY294002作用于SMMC-7221细胞,并设对照组和实验组(LY294002:5、10、20、40μmol/L),MTT法检测LY294002作用24、4... 目的:探讨PI3K/AKT(磷脂酰肌醇-3-激酶/蛋白激酶B)信号转导通路在人肝癌细胞株SMMC-7221生长和黏附中的作用机制.方法:应用LY294002作用于SMMC-7221细胞,并设对照组和实验组(LY294002:5、10、20、40μmol/L),MTT法检测LY294002作用24、48、72、96h后,对SMMC-7221细胞增殖的影响;采用肿瘤细胞-基质黏附实验检测对照组和干预组SMMC-7221黏附能力的变化;流式细胞仪检测肝癌细胞黏附分子CD44s表达情况;细胞免疫化学S-P法检测SMMC-7221细胞血管内皮生长因子(vascular endothelial growth factor,VEGF)和CD44V6蛋白表达.结果:LY294002对SMMC-7221细胞的增殖有抑制作用,呈剂量和时间依赖性;5、10mol/L的LY294002作用于肝癌细胞后与对照组相比CD44s,VEGF,CD44V6蛋白表达下降(CD44s:42.84%±6.35%,20.21%±4.5%vs89.23%±3.91%,P<0.01;VEGF:103.11±18.60,68.99±15.99vs137.84±22.50,P<0.01;CD44V6:47.33±6.15,33.09±5.23vs61.36±7.39,P<0.01);5、10μmol/L的LY294002干预后与对照组相比SMMC-7221黏附能力下降(0.498±0.024,0.407±0.029vs0.616±0.080,P<0.01).结论:阻断PI3K/AKT信号传导通路,肝癌细胞生长受到抑制、黏附能力下降.LY294002抑制肝癌细胞黏附力的作用机制与通过降低CD44V6、CD44s和VEGF水平有关. 展开更多
关键词 PI3K/AKT信号转导通路 LY294002 SMMC-7221 血管内皮生长因子 cd44S cd44v6 MTT法 流式细胞术 细胞免疫化学
下载PDF
CD44V6在非小细胞肺癌中的表达及其预后意义 被引量:20
14
作者 戴备军 赵仲生 《实用肿瘤杂志》 CAS 北大核心 1998年第4期214-216,共3页
应用免疫组化S-P方法对62例有55年随访资料的非小细胞肺癌(NSCLC)组织进行CD44V6的检测,以探讨其在NSCLC组织中的表达及其预后的意义。测得NSCLC的CD44V6阳性表达率为69.3%,和组织分型无明... 应用免疫组化S-P方法对62例有55年随访资料的非小细胞肺癌(NSCLC)组织进行CD44V6的检测,以探讨其在NSCLC组织中的表达及其预后的意义。测得NSCLC的CD44V6阳性表达率为69.3%,和组织分型无明显相关;CD44V6阳性表达和NSCLC的临床分期、淋巴结转移以及3年、5年术后生存率有关(P<0.005~0.05)。结果还表明CD44V6强阳性表达者均为>6cm的肺癌。提示CD44V6表达强度和肿瘤大小有关。NSCLC中,CD44V6阳性表达者容易发生淋巴结转移,预后较差。上述结果表明。 展开更多
关键词 肺肿瘤 cd44v6 免疫组织化学 非小细胞肺癌
下载PDF
检测恶性腹水中VEGF、CD44v6和MMP-2、MMP-9的临床意义 被引量:16
15
作者 孙晓敏 董卫国 +2 位作者 余保平 罗和生 于皆平 《癌症》 SCIE CAS CSCD 北大核心 2004年第1期85-89,共5页
背景及目的:恶性腹水中找到癌细胞有确诊意义,但阳性率很低。因此从腹水中寻找理想的癌性标记物已成为当前研究的主要课题。本课题拟通过检测腹水中血管内皮生长因子(vascularendothelialgrowthfactor,VEGF)、细胞粘附分子CD44v6、基质... 背景及目的:恶性腹水中找到癌细胞有确诊意义,但阳性率很低。因此从腹水中寻找理想的癌性标记物已成为当前研究的主要课题。本课题拟通过检测腹水中血管内皮生长因子(vascularendothelialgrowthfactor,VEGF)、细胞粘附分子CD44v6、基质金属蛋白酶-2,-9(matrixmetalloproteinase-2,-9,MMP-2,-9)的水平并进行分析,以期为临床腹水诊治提供科学依据。方法:收集肝硬化腹水36例、结核性腹水8例、恶性腹水23例。采用ELISA法检测VEGF、CD44v6含量,用明胶酶谱法检测MMP-2,-9活性。结果:恶性腹水中VEGF、CD44v6含量分别为(640.74±264.81)ng/L、(89.22±38.20)μg/L,明显高于肝硬化腹水犤(67.05±51.91)ng/L,(44.79±18.02)μg/L犦和结核性腹水犤(88.25±24.12)ng/L,(50.25±12.57)μg/L犦(P<0.01)。肝硬化腹水、结核性腹水不能检出MMP-2,-9,而恶性腹水MMP-2检出率为87.0%,MMP-9检出率为78.3%。结论:恶性腹水中VEGF、CD44v6水平显著升高而MMP-2,-9阳性。联合检测腹水中VEGF、CD44v6、MMP-2,-9的水平可作为临床良、恶性腹水的鉴别诊断依据之一。 展开更多
关键词 检测 恶性腹水 vEGF cd44v6 MMP-2 MMP-9 鉴别诊断
下载PDF
CD44V6在大肠癌转移中作用机理的研究 被引量:18
16
作者 李祖国 丁彦青 +2 位作者 邓永键 郭君其 朱梅刚 《中华医学杂志》 CAS CSCD 北大核心 1998年第10期729-732,共4页
目的研究CD44V6在大肠癌转移中的作用机理。方法应用羊膜代基底膜模型并将大肠癌肿瘤细胞与羊膜及血管内皮共同培养,研究CD44V6对大肠癌细胞粘附基底膜与血管内皮的影响。采用共聚焦图像三维重构分析技术研究CD44V6... 目的研究CD44V6在大肠癌转移中的作用机理。方法应用羊膜代基底膜模型并将大肠癌肿瘤细胞与羊膜及血管内皮共同培养,研究CD44V6对大肠癌细胞粘附基底膜与血管内皮的影响。采用共聚焦图像三维重构分析技术研究CD44V6对大肠癌细胞骨架的影响。使用激光漂白后荧光恢复技术研究CD44V6对大肠癌细胞缝隙连接细胞间通讯的影响。结果CD44V6单抗能抑制大肠癌细胞对羊膜及血管内皮的粘附和浸润能力,影响大肠癌细胞骨架蛋白的构型和分布。但对大肠癌细胞缝隙连接细胞间通讯无明显影响。结论CD44V6变异体能促进大肠癌细胞与血管内皮细胞及基底膜的粘附和浸润,并影响细胞骨架蛋白的构型和分布,增强肿瘤细胞的运动能力。 展开更多
关键词 大肠肿瘤 肿瘤转移 cd44v6 作用机理
原文传递
CD44v6 in peripheral blood and bone marrow of patients with gastric cancer as micro-metastasis 被引量:23
17
作者 Dao-Rong Wang Guo-Yu Chen +4 位作者 Xun-Liang Liu Yi Miao Jian-Guo Xia Lin-Hai Zhu Dong Tang 《World Journal of Gastroenterology》 SCIE CAS CSCD 2006年第1期36-42,共7页
AIM: To detect the expression of CD44 correlated with the ability of micro-metastasis in peripheral blood and bone marrow of patients with gastric cancer and to deduce its clinical significance. METHODS: Preoperativ... AIM: To detect the expression of CD44 correlated with the ability of micro-metastasis in peripheral blood and bone marrow of patients with gastric cancer and to deduce its clinical significance. METHODS: Preoperative peripheral blood and bone marrow specimens from 46 patients with gastric cancer and 6 controls were studied by semi-quantitative RTPCR amplification of CD44v6mRNA. Preoperative and postoperative peripheral blood specimens from 40 patients with gastric cancer and 14 controls were studied by quantitative RT-PCR amplification of CD44v6mRNA in the corresponding period. RESULTS: Semi-quantitative RT-PCR amplification showed that CD44v6mRNA expression of peripheral blood and bone marrow was positive in 39 (84.8%) and 40 (86.9%) of 46 patients with gastric cancer, respectively. In peripheral blood, CD44v6mRNA expression was positive for diffuse type in 30 (93.8%) of 32 patients and for intestinal type in 9 (64.3%) of 14 patients. On the other hand, in bone marrow, CD44v6mRNA expression was positive for diffuse type in 31 (96.9%) of 32 patients and for intestinal type in 10 (71.4%) of 14 patients. There was a significant difference between the diffuse type and intestinal type. Quantitative RTopCR amplification demonstrated that CD44v6mRNA was not expressed in the peripheral blood of controls and CD44v6mRNA expression was positive for preoperative peripheral blood in 40 patients with gastric cancer, the expression levels being from 4.9 × 10^2 to 3.2× 10^5 copies/g RNA. The average expression level of CD44v6mRNA in peripheral blood was 3.9 × 10^10 copies/g RNA. The expression levels of CD44v6mRNA in peripheral blood in gastric cancer patients after curative operation increased from 5.5 × 100 to 7.6 × 10 copies/g RNA (P = 0.00496). After curative operation, the expression level decreased markedly. CONCLUSION: Semi-quantitative and quantitative RTPCR amplification for CD44v6mRNA is a sensitive and specific method for the detection of micro-metastasis in peripheral blood a 展开更多
关键词 Gastric cancer Micro-metastasis Peripheral blood Bone marrow cd44v6
下载PDF
FOLFOX4、SOX化疗方案治疗晚期胃癌的疗效及对血清生物活性因子及预后的影响 被引量:23
18
作者 刘浩 何阳科 +3 位作者 宋旭彤 朱学强 敖睿 黄慧 《癌症进展》 2019年第11期1282-1285,1309,共5页
目的探讨奥沙利铂+亚叶酸钙+5-氟尿嘧啶(FOLFOX4)、奥沙利铂+替吉奥(SOX)化疗方案治疗晚期胃癌的疗效及对血清基质金属蛋白酶9(MMP9)、CD44v6、血管内皮细胞生长因子C(VEGFC)、转化生长因子-β1(TGF-β1)水平和预后的影响。方法根据治... 目的探讨奥沙利铂+亚叶酸钙+5-氟尿嘧啶(FOLFOX4)、奥沙利铂+替吉奥(SOX)化疗方案治疗晚期胃癌的疗效及对血清基质金属蛋白酶9(MMP9)、CD44v6、血管内皮细胞生长因子C(VEGFC)、转化生长因子-β1(TGF-β1)水平和预后的影响。方法根据治疗方法不同将112例晚期胃癌患者分为对照组与观察组,每组56例。对照组患者采用FOLFOX4方案化疗,观察组患者采用SOX方案化疗。比较两组患者的近期疗效、远期生存情况、不良反应发生情况,并对两组患者治疗前后的血清MMP9、CD44v6、VEGFC、TGF-β1水平进行比较。结果治疗结束后,两组患者的疾病控制率、客观缓解率比较,差异均无统计学意义(P﹥0.05)。化疗过程中,两组患者白细胞减少、血小板减少、乏力、恶心、呕吐、口腔黏膜炎、肝肾功能不全、神经功能异常的发生率比较,差异均无统计学意义(P﹥0.05)。两组患者治疗后的血清MMP9、CD44v6、VEGFC、TGF-β1水平均明显低于本组治疗前(P﹤0.01);观察组患者治疗后的血清MMP9、CD44v6、VEGFC、TGF-β1水平均低于对照组治疗后(P﹤0.05)。观察组患者的2年生存率高于对照组(P﹤0.05)。结论SOX化疗方案治疗晚期胃癌的远期疗效优于FOLFOX4方案,可能与降低血清MMP9、CD44v6、VEGFC、TGF-β1水平有关。 展开更多
关键词 FOLFOX4 SOX 晚期胃癌 MMP9 cd44v6 vEGFC TGF-β1
下载PDF
Role of VEGF and CD44v6 in differentiating benign from malignant ascites 被引量:21
19
作者 Wei-Guo Dong Xiao-Min Sun Bao-Ping Yu He-Sheng Luo Jie-Ping Yu, Department of Gastroenterology, Renmin Hospital, Wuhan University, Wuhan 430060, Hubei Province, China 《World Journal of Gastroenterology》 SCIE CAS CSCD 2003年第11期2596-2600,共5页
AIM: To detect the vascular endothelial growth factor (VEGF)and soluble splice variant 6 of CD44 (sCD44v6) levels in ascites and to explore their role in differentiating benign from malignant ascites.METHODS: Cirrhoti... AIM: To detect the vascular endothelial growth factor (VEGF)and soluble splice variant 6 of CD44 (sCD44v6) levels in ascites and to explore their role in differentiating benign from malignant ascites.METHODS: Cirrhotic ascites (n=36), tuberculosis ascites (n=8) and malignant ascites (n=23) were collected and studied. Concentrations of soluble VEGF and sCD44v6 in various kinds of ascites (n=67) were measured using a sandwich enzyme-linked immunoadsorbent assay.RESULTS: VEGF and sCD44v6 levels in malignant ascites were 640.74±264.81 pg/ml and 89.22±38.20 ng/ml,respectively, both of which were significantly higher than those in cirrhotic ascites and tuberculous ascites (q=18.98,11.89 and q=8.92, 5.09; P<0.01). However, the levels of VEGF and sCD44v6 in cirrhotic and tuberculous ascites had no significant difference (q=0.48, 0.75; P>0.05).Furthermore, VEGF levels in malignant ascites in patients with ovarian cancer were higher than those with gastric and colon cancer (q=5.03, 6.79; P<0.01, respectively). But differences of VEGF levels between gastric and colon cancer were not significant (q=1.90, P>0.05). Whereas, sCD44v6 levels in malignant ascites from patients with ovadan, gastric and colon cancer had no significant difference (q=0.06, 0.91,0.35;P>0.05, respectirely). In comparison with cirrhotic and tuberculous ascites, when the upper limit of its VEGF mean levels 119.44 pg/ml (70.90±48.54) and sCD44v6 mean levels 63.59 ng/ml (44.42±19.17) was taken as the minimum cutoff limit, the sensitivity and specificity of VEGF and sCD44v6 of this assay to the diagnos is of malignant ascites were 91.3 %, 90.9 % and 73.9 %, 88.7 % respectively.CONCLUSION: Elevated levels of VEGF and sCD44v6 may be useful in differential diagnosis of benign and malignant ascites. 展开更多
关键词 恶性腹水 vEGF cd44v6 晚期肿瘤 肿瘤转移 发病机制
下载PDF
Expression and correlation of CD44v6, vascular endothelial growth factor, matrix metalloproteinase-2, and matrix metalloproteinase-9 in Krukenberg tumor 被引量:20
20
作者 Ge Lou Ying Gao Xiao-Ming Ning Qi-Fan Zhang 《World Journal of Gastroenterology》 SCIE CAS CSCD 2005年第32期5032-5036,共5页
AIM: To explore the expression and correlation of CD44v6, vascular endothelial growth factor (VEGF), matrix metalloproteinase (MMP)-2 and matrix metalloproteinase (MMP)-9 in Krukenberg and primary epithelial ov... AIM: To explore the expression and correlation of CD44v6, vascular endothelial growth factor (VEGF), matrix metalloproteinase (MMP)-2 and matrix metalloproteinase (MMP)-9 in Krukenberg and primary epithelial ovarian carcinoma. METHODS: The expressions of CD44v6, VEGF, MMP-2 and MMP-9 were detected by immunohistochemical method in 20 cases of normal ovarian tissues, 38 cases of Krukenberg tumor and 45 cases of primary epithelial ovarian carcinoma. RESULTS: The expression of CD44v6 (primary epithelial ovarian carcinoma tissue vs normal ovarian tissue: χ^2= 4.516, P= 0.034; Krukenberg tumor tissue vsnormal ovarian tissue: χ^2 = 19.537, P = 0.001) and VEGF (primary epithelial ovarian carcinoma tissue vs normal ovarian tissue: P = 0.026; Krukenberg tumor tissue vs normal ovarian tissue: χ^2 = 22.895, P = 0.001) was significantly higher in primary epithelial ovarian carcinoma tissue and Krukenberg tumor tissue than in normal ovarian tissue. The positive expression rate of MMP-2 and MMP-9 was 0% in the normal ovarian tissue. The positive expression rate of CD44v6 ( χ^2= 10.398, P= 0.001), VEGF ( χ^2= 13.149, P = 0.001), MMP-2 ( χ^2 = 33.668, P = 0.001) and MMP-9 ( χ^2= 38.839, P = 0.001) was remarkably higher in Krukenberg tumor than in primary epithelial ovarian carcinoma. The correlation of CD44v6, VEGF, MMP-2, and MMP-9 was observed in primary epithelial ovarian carcinoma and Krukenberg tumor. CONCLUSION: CD44v6, VEGF, MMP-2, and MMP-9 are involved in ovarian carcinoma, gastric cancer and Krukenberg tumor. Detection of CD44v6, VEGF, MMP-2 and MMP-9 may contribute to the diagnosis of ovarian carcinoma, gastric cancer, and Krukenberg tumor. 展开更多
关键词 cd44v6 vEGF MMPs Krukenberg tumor
下载PDF
上一页 1 2 77 下一页 到第
使用帮助 返回顶部